semaglutide and naltrexone WEIGHT LOSS MEDICATION As you've probably read my prior posts regarding Obesity you must know by now that Obesity is as a chronic disease we are treating it as such. Weight-loss Semaglutide (GLP-1) and Low-Dose Naltrexone

36 The orobuccal absorptive surface area is approximately 200 cm 2 , supplied by a rich vascular network

Microbial growth slows dramatically under refrigeration

Integrity in the process

Uses * Control blood sugar in type 2 diabetes * Reduce risk of cardiovascular events in some diabetic patients * Promotes weight loss * Sometimes used off-label for obesity management Mechanism of action Ozempic works by: * Increasing insulin release when blood glucose is high * Reducing glucagon secretion * Slowing gastric emptying * Reducing appetite Administration * Given as a subcutaneous injection * Usually injected once weekly * Common injection sites: * Abdomen * Thigh * Upper arm Common side effects * Nausea * Vomiting * Diarrhea * Constipation * Abdominal pain * Loss of appetite Serious adverse effects * Pancreatitis * Gallbladder disease * Severe dehydration * Kidney injury * Hypoglycemia (especially with insulin or sulfonylureas) * Possible thyroid C-cell tumor risk Contraindications * Personal or family history of medullary thyroid carcinoma * Multiple endocrine neoplasia type 2 (MEN2) * Severe hypersensitivity to semaglutide Monitoring * Blood glucose and HbA1c * Weight * Renal function * Signs of pancreatitis Important points * Not used for type 1 diabetes * Should be combined with diet and exercise * Dose is increased gradually to reduce gastrointestinal side effects * Stopping suddenly may lead to weight regain or worsening glucose control Drug interactions Caution with: * Insulin * Sulfonylureas * Oral medications affected by delayed gastric emptying La reprise du poids qui peut dpasser parfois le poids initial existe t il en cas d'arrt progressif du mdicament , auquel cas ce serait un traitement vie,avec tous les risques de complications graves

A qualified healthcare provider should evaluate whether dose adjustment, timing changes, or alternative formulations may improve tolerability

Environmental contaminants and toxins Gastrointestinal toxins we absorb or consume can damage our gut lining and disorder our microbiome